|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| License | |||||
| Total revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue | |||||
| Research and development: | |||||
| Noncash compensation | |||||
| Other research and development | |||||
| Total research and development | |||||
| Selling, general and administrative: | |||||
| Noncash compensation | |||||
| Other selling, general and administrative | |||||
| Total selling, general and administrative | |||||
| Total costs and expenses | |||||
| Operating income | |||||
| Other expense (income): | |||||
| Interest expense | |||||
| Other income | |||||
| Total other expense | |||||
| Net income before taxes | |||||
| Income tax benefit (expense) | |||||
| Net income | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...